Royal Bank Of Canada Abeona Therapeutics Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.17 - $8.05 $1,857 - $4,717	-586 Reduced 73.25%	214 $0
Q1 2024 Nov 05, 2024	BUY	$4.07 - $8.68 $2,385 - $5,086	586 Added 273.83%	800 $5,000
Q1 2024 May 15, 2024	SELL	$4.07 - $8.68 $850 - $1,814	-209 Reduced 20.71%	800 $5,000
Q4 2023 Feb 14, 2024	BUY	$3.71 - $5.14 $3,717 - $5,150	1,002 Added 14314.29%	1,009 $5,000
Q3 2023 Nov 14, 2023	BUY	$2.98 - $4.43 $20 - $31	7 New	7 $0

26.9M

614K

45K

Ticker ABEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,950,380
Market Cap $33.9M
Description
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.